212 related articles for article (PubMed ID: 28024930)
1. Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial.
Ix JH; Katz R; Bansal N; Foster M; Weiner DE; Tracy R; Jotwani V; Hughes-Austin J; McKay D; Gabbai F; Hsu CY; Bostom A; Levey AS; Shlipak MG
Am J Kidney Dis; 2017 Mar; 69(3):410-419. PubMed ID: 28024930
[TBL] [Abstract][Full Text] [Related]
2. Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.
Weiner DE; Park M; Tighiouart H; Joseph AA; Carpenter MA; Goyal N; House AA; Hsu CY; Ix JH; Jacques PF; Kew CE; Kim SJ; Kusek JW; Pesavento TE; Pfeffer MA; Smith SR; Weir MR; Levey AS; Bostom AG
Am J Kidney Dis; 2019 Jan; 73(1):51-61. PubMed ID: 30037726
[TBL] [Abstract][Full Text] [Related]
3. Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial.
Park M; Katz R; Shlipak MG; Weiner D; Tracy R; Jotwani V; Hughes-Austin J; Gabbai F; Hsu CY; Pfeffer M; Bansal N; Bostom A; Gutierrez O; Sarnak M; Levey A; Ix JH
Am J Transplant; 2017 Oct; 17(10):2640-2649. PubMed ID: 28371433
[TBL] [Abstract][Full Text] [Related]
4. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.
Malhotra R; Katz R; Weiner DE; Levey AS; Cheung AK; Bostom AG; Ix JH
Am J Hypertens; 2019 Aug; 32(9):816-823. PubMed ID: 31179500
[TBL] [Abstract][Full Text] [Related]
5. Urinary Dickkopf 3 Is Not an Independent Risk Factor in a Cohort of Kidney Transplant Recipients and Living Donors.
Jehn U; Altuner U; Henkel L; Menke AF; Strauss M; Pavenstädt H; Reuter S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791413
[TBL] [Abstract][Full Text] [Related]
6. Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.
Bansal N; Carpenter MA; Weiner DE; Levey AS; Pfeffer M; Kusek JW; Cai J; Hunsicker LG; Park M; Bennett M; Liu KD; Hsu CY
J Am Soc Nephrol; 2016 Jul; 27(7):2109-21. PubMed ID: 26538631
[TBL] [Abstract][Full Text] [Related]
7. Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.
Jotwani V; Katz R; Ix JH; Gutiérrez OM; Bennett M; Parikh CR; Cummings SR; Sarnak MJ; Shlipak MG
Am J Kidney Dis; 2018 Aug; 72(2):205-213. PubMed ID: 29602632
[TBL] [Abstract][Full Text] [Related]
8. Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.
Miller LM; Rifkin D; Lee AK; Kurella Tamura M; Pajewski NM; Weiner DE; Al-Rousan T; Shlipak M; Ix JH
Am J Kidney Dis; 2021 Oct; 78(4):530-540.e1. PubMed ID: 33647393
[TBL] [Abstract][Full Text] [Related]
9. Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.
Merhi B; Shireman T; Carpenter MA; Kusek JW; Jacques P; Pfeffer M; Rao M; Foster MC; Kim SJ; Pesavento TE; Smith SR; Kew CE; House AA; Gohh R; Weiner DE; Levey AS; Ix JH; Bostom A
Am J Kidney Dis; 2017 Sep; 70(3):377-385. PubMed ID: 28579423
[TBL] [Abstract][Full Text] [Related]
10. Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure.
Bostom A; Steubl D; Garimella PS; Franceschini N; Roberts MB; Pasch A; Ix JH; Tuttle KR; Ivanova A; Shireman T; Kim SJ; Gohh R; Weiner DE; Levey AS; Hsu CY; Kusek JW; Eaton CB
Am J Nephrol; 2018; 47(4):275-282. PubMed ID: 29698955
[TBL] [Abstract][Full Text] [Related]
11. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
Dad T; Tighiouart H; Joseph A; Bostom A; Carpenter M; Hunsicker L; Kusek JW; Pfeffer M; Levey AS; Weiner DE
Am J Kidney Dis; 2016 Aug; 68(2):277-286. PubMed ID: 26947217
[TBL] [Abstract][Full Text] [Related]
12. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
[TBL] [Abstract][Full Text] [Related]
13. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
[TBL] [Abstract][Full Text] [Related]
14. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH
Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914
[TBL] [Abstract][Full Text] [Related]
15. Plasma Lead Concentration and Risk of Late Kidney Allograft Failure: Findings From the TransplantLines Biobank and Cohort Studies.
Sotomayor CG; Giubergia F; Groothof D; Ferreccio C; Nolte IM; Navis GJ; Gomes-Neto AW; Kremer D; Knobbe TJ; Eisenga MF; Rodrigo R; Touw DJ; Bakker SJL;
Am J Kidney Dis; 2022 Jul; 80(1):87-97.e1. PubMed ID: 34871698
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
[TBL] [Abstract][Full Text] [Related]
17. Predicting kidney transplantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections.
Talreja H; Akbari A; White CA; Ramsay TO; Hiremath S; Knoll G
Am J Kidney Dis; 2014 Dec; 64(6):962-8. PubMed ID: 25304983
[TBL] [Abstract][Full Text] [Related]
18. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C
Transplantation; 2003 Jun; 75(12):2113-9. PubMed ID: 12829921
[TBL] [Abstract][Full Text] [Related]
19. Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study.
Bansal N; Katz R; Himmelfarb J; Afkarian M; Kestenbaum B; de Boer IH; Young B
Nephrol Dial Transplant; 2016 Dec; 31(12):2057-2064. PubMed ID: 27257276
[TBL] [Abstract][Full Text] [Related]
20. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
Hart A; Jackson S; Kasiske BL; Mauer MS; Najafian B; Matas AJ; Spong R; Ibrahim HN
Transplantation; 2014 May; 97(10):1066-71. PubMed ID: 24503762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
